From a survey of nine analysts the consensus for FY19 on a pre-IFRS16, pre-exceptional basis is:

 

Range 

Average (Mean)

Sales (£m) 

948.7 - 979.2

961.6

EBITDA (£m) 

119.1 – 121.9

120.7

EBIT (£m)* 

51.9 - 60.0

55.0

Net income (£m)*

20.0 - 23.1

22.1

EPS (p)* 

5.0 - 5.8

5.5

 

* Note: only eight analysts contributed to these measures

931.1m
revenue in 2018
7,700+
dedicated clinicians and clinical support staff
96%
patients ‘Likely’ or ‘Extremely Likely’ to recommend Spire Healthcare